Editas Medicine, Inc. (EDIT)

2.34 -0.01 (-0.43%) USD  |  NASDAQ  |  Dec 19, 16:00
2.35 +0.01 (+0.43%) After-Hours: 20:00
More

Editas Medicine EV to Revenues (Forward)

EV to Revenues (Forward) Chart

View EV to Revenues (Forward) for EDIT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Revenues (Forward) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Forward EV / Revenues Definition

View Forward EV / Revenues Definition
Start Trial

Forward EV / Revenues is the current Enterprise value to the predicted revenues ratio for the current fiscal year. Keep in mind, analyst estimates are not set in stone, and can often be wrong.

Read full definition.

EV to Revenues (Forward) Range, Past 5 Years

View EV to Revenues (Forward) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues (Forward) Benchmarks

View EV to Revenues (Forward) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Arcutis Biotherapeutics, Inc. Upgrade
Daré Bioscience, Inc. Upgrade
Cogent Biosciences, Inc. --
Janux Therapeutics, Inc. Upgrade